Paul Strickland Scanner Centre is supporting a ground-breaking study that could lead to simple blood tests being used to diagnose cancer and choose the right treatment within the next 5-10 years.

back to all news
Pierre
30 November, 2018

Paul Strickland Scanner Centre is supporting a ground-breaking study that could lead to simple blood tests being used to diagnose cancer and choose the right treatment within the next 5-10 years.

The CICATRIX study uses the number of circulating tumour cells and/or white blood cells, or the expression or activation of certain genetic information in these cells, to detect what is likely to happen to a patient’s cancer earlier, and more accurately, than currently.

The research pulls together three great institutions – Mount Vernon Cancer Centre, where lots of patients are being treated, Paul Strickland Scanner Centre (where patients are being scanned), and Brunel University – who do the blood work for the study,” says Dr Tom Smith, senior Clinical Research Fellow at Mount Vernon. The funding for Dr Smith’s post is jointly funded by Paul Strickland Scanner Centre and Mount Vernon Cancer Centre.

Read the full story

categories
2018
popular articles